<img alt="" src="https://secure.lote1otto.com/219869.png" style="display:none;">
Skip to content

Cytel Publishes Inaugural Sustainability Report


With the ongoing changes inherent in the life sciences industry comes heightened expectations for companies to take accountability for their environmental, social, and governance (ESG) impacts. Click below to read Cytel’s inaugural Sustainability Report, in which you will learn about Cytel’s ESG strategy, objectives, and current state. 

Drawing from core values of accountability, innovation, and collaboration, Cytel has embraced these expectations as an opportunity to showcase its commitment to its employees, customers, and communities. Throughout 2022, Cytel made significant strides in formalizing its ESG strategy and implementation plan, which outlines long-term initiatives, short-term actions, and key performance indicators (KPIs) against which progress is measured. 

To read Cytel’s Sustainability Report 2022, click the button below:


Download Report

Read more from Perspectives on Enquiry & Evidence:

Sorry no results please clear the filters and try again

Setting Expectations for Formal Interim Analyses with Independent Data Monitoring Committees

Independent data monitoring committees (IDMCs) review ongoing clinical trial data to make recommendations regarding...
Read more

How to Ask the Right Questions at an Authority Meeting

As a drug developer, you have to live with the answers and comments you get from regulatory authorities. Therefore,...
Read more

How to Create and Optimize a Clinical Development Plan

A clinical development plan — a comprehensive strategy for developing an investigational product through regulatory...
Read more
contact iconSubscribe back to top